Accellacare-DuPage Medical Group

Raleigh, North Carolina 27609

0 studies enrolling now · 1 studies all time

What they study most

Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer

Studies at this site

• Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations — Stopped early